title: Prospective, randomised study on antibiotic prophylaxis in colorectal surgery. Is it really necessary to use oral antibiotics?
abstract: OBJECTIVE
  The use of prophylactic antibiotics in addition to mechanical cleansing is the current standard of care prior to colonic surgery. The question of whether the antibiotics should be administered intravenously or orally, or by both routes, remains controversial. Our aim was to compare three methods of prophylactic antibiotic administration in elective colorectal surgery.
  
  
  METHODS
  Three hundred consecutive elective colorectal resections were studied. All patients had preoperative mechanical colon cleansing with oral sodium phosphate and intravenous antibiotic prophylaxis with cefoxitin (one dose before skin incision and two postoperative doses). Patients were randomised to one of the following three groups: group A: three doses of oral antibiotic (neomycin and metronidazole) at the time of mechanical colon cleansing; group B: one dose of oral antibiotic; group C: no oral antibiotics. All patients were followed during their hospital stay and at 7, 14 and 30 days post-surgery.
  
  
  RESULTS
  Vomiting occurred in 31%, 11% and 9% of the studied patients (groups A, B and C, respectively) (p<0.001). Nausea was present in 44%, 18% and 13% of patients (p<0.001). Abdominal pain was recorded in 13%, 10% and 4% of patients (p: 0.077). Wound infection was present in 7%, 8% and 6% and suture dehiscence occurred in 2%, 2% and 3% of the patients in the three groups (no differences among them). Neither were differences found among the three groups in terms of urinary infections, pneumonia, postoperative ileus or intra-abdominal abscess.
  
  
  CONCLUSIONS
  The addition of three doses of oral antibiotics to intravenous antibiotic prophylaxis is associated with lower patient tolerance in terms of increased nausea, vomiting and abdominal pain, and has shown no advantages in the prevention of postoperative septic complications. Therefore, we recommend that oral antibiotics should not be used prior to colorectal surgery.
authors.affiliation: Department of General Surgery, Colorectal Surgery Unit, Hospital Valle de Hebron, Autonomous University of Barcelona, 4th Floor, Pg Valle de Hebron 119-129, Barcelona, 08035, Spain. eespin@vhebron.net
authors.forename: Eloy
authors.initials: E
authors.lastname: Espin-Basany
authors.forename: Jose Luis
authors.initials: JL
authors.lastname: Sanchez-Garcia
authors.forename: Manuel
authors.initials: M
authors.lastname: Lopez-Cano
authors.forename: Roberto
authors.initials: R
authors.lastname: Lozoya-Trujillo
authors.forename: Meritxell
authors.initials: M
authors.lastname: Medarde-Ferrer
authors.forename: Lluis
authors.initials: L
authors.lastname: Armadans-Gil
authors.forename: Laia
authors.initials: L
authors.lastname: Alemany-Vilches
authors.forename: Manuel
authors.initials: M
authors.lastname: Armengol-Carrasco
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D019072:Antibiotic Prophylaxis / Q000379:methods*; D003082:Colectomy; D015179:Colorectal Neoplasms / Q000601:surgery*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage*; D008875:Middle Aged; D009355:Neomycin / Q000008:administration & dosage*; D011446:Prospective Studies; D013530:Surgical Wound Infection / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D008795:Metronidazole; D009355:Neomycin